Insights from those benefits checks reveal: More patients have coverage than youd think: Close to half of patients (47%) have coverage of GLP-1s for weight loss and, of those, most have coverage of more than one medication
It helps keep my mist habit funded and this blog running
The average HbA1c reduction may have been attenuated by floor effect, as a high proportion of participants approached near-normal glycaemic levels
Cavalcanti OB, Barquera S, Baur L, Busch V, Buse K, Dietz B, et al
For a holisitc view of the treatment landscape for MASH, our clinical insights white paper, Metabolic dysfunction-associated steatohepatitis (MASH) A new era in liver health, provides a comprehensive look at emerging approaches to liver care
Famularo, G., Moretti, S., Alesse, E., Trinchieri, V., Angelucci, A., Santini, G., Cifone, G., and De, Simone C